HopeStage
Back to all studies
TerminatedNCT03544333

Boost rTMS for Auditory Verbal Hallucinations

Device studyAges 18–65United StatesSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
ManhassetSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 16, 2018
Recruitment status
Terminated
Enrollment listed in the registry
5
Sponsor
Northwell Health
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT03544333
Official title
Show the full official title

Boost rTMS for AVH - Therapeutic Response and Neurobiological Prediction Markers in Auditory Verbal Hallucinations

Recruitment & locations

Terminated

Manhasset

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Northwell Health.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies